Work

Real‐World Treatment Patterns in AERD: An Analysis of ATAD, Biologics, and Combination Therapy

Year: 2025

Type: article

Abstract: KEY POINTS: Contemporary aspirin exacerbated respiratory disorder (AERD) therapy commonly includes aspirin desensitization (55%) and biologics (48%). Aspirin desensitization therapy has higher discontinuation rates than biologics. Patients receiving biologics are younger, and ∼25% of the patients switch to other agents.

Source: International Forum of Allergy & Rhinology

DOI: 10.1002/alr.70072

Authors: Nitish Kumar, Tyson Pace, Pedro Lança Gomes, Michael J. Marino, Amar Miglani, Devyani Lal

Institutions: Mayo Clinic, Mayo Clinic Hospital, Mayo Clinic in Arizona, Universidade de Brasília

Language: English

Topic: Asthma and respiratory diseases

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $4,100